Ovarian Cancer

Management of STIC in Patients Undergoing RRSO

Ovarian Borderline Tumors

GYOEDU Resident: Ovarian Cancer Part 3

HIPEC in ovarian cancer

Korean HIPEC trial

The addition of HIPEC after interval cytoreductive surgery following neoadjuvant chemotherapy provided significant improvements in PFS and OS.

Mucinous Ovarian Carcinoma

GOG 241: Phase III Randomized Trial in Patients with Mucinous Epithelial Ovarian Cancer

Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.

Germ Cell Tumors of the Ovary

Granulosa Cell Tumors

Secondary Debulking Mini-Tutorial